Clarus Therapeutics Holdings Inc. (NASDAQ:CRXT) trading with a subtraction of -$0.2 to $5.09 on Thursday, a downside of -3.79 percent. An average of 5,241,466 shares of common stock have been traded in the last five days. There was a gain of $1.45 in the past week. The last 20 days have seen an average of 2,152,902 shares traded, while the 50-day average volume stands at 1,809,581.
CRXT stock has decreased by -29.47% in the last month. The company shares reached their 1-month lowest point of $3.43 on 10/07/21. Shares of the company touched a low of $3.43 and a high of $31.24 in 52 weeks. In spite of this, the price is down -83.71% from the 52-week high.
A Backdoor Way To Profit From Today’s Crypto Bull Market
In any crypto bull market, there's a lot of money to be made.
But what if we told you the best opportunities are not cryptocurrencies themselves… but instead, simply crypto stocks?
This strategy is simply and ridiculously easy.
Here are 6 ways to gain exposure to crypto outside the norm. This is arguably the safest bet you can make.
Clarus Therapeutics Holdings Inc. (CRXT) has a trailing price-to-earnings (P/E) ratio of 11.50, which compares with the 23.00 for the broader industry and 32.77 for the sector. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 11.25, the price-to-book (PB) ratio at 0.79.
The quick ratio of Clarus Therapeutics Holdings Inc. for the recent quarter was 0.30, and the current ratio was 0.30, indicating that the company is not able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.00 for the recent quarter.
From a technical analysis perspective, let’s take a brief look at Clarus Therapeutics Holdings Inc. (CRXT) price momentum. RSI 9-day as of the close on 13 October was 50.53%, suggesting the stock is Neutral, with historical volatility in this time frame at 172.16%.
As of today, CRXT’s price is $4.40 +39.72% or $1.45 from its 5-day moving average. CRXT is currently trading -34.87% lower than its 20-day SMA and -49.31% lower than its 100-day SMA. However, the stock’s current price level is -49.80% below the SMA50.
The stochastic %K and %D were 42.83% and 27.02%, respectively, and the average true range (ATR) was 0.87. With the 14-day stochastic at 51.54% and the average true range at 0.94, the RSI (14) stands at 43.98%. The stock has reached 0.69 on the 9-day MACD Oscillator while the 14-day reading was at 0.29.
The consensus rating for Clarus Therapeutics Holdings Inc. (CRXT) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell CRXT, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 5 others rate it as a “buy”.
What is CRXT’s price target for the next 12 months?
Analysts predict a range of price targets between $10.00 and $20.00, with a median target of $12.00. Taking a look at these predictions, the average price target given by analysts for Clarus Therapeutics Holdings Inc. (CRXT) stock is $13.40.